Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -23.46-24.787.6324.25407.44

What is the latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS is -23.46 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-23.46
Mar2024-24.78
Mar20237.63
Mar202224.25
Mar2021407.44

How is Core EBITDA Growth of BALAXI PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -23.46
Negative
Mar2024 -24.78
Negative
Mar2023 7.63
-68.54
Mar2022 24.25
-94.05
Mar2021 407.44 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹102.9 Cr -0.2% -15.4% -71.8% Stock Analytics
ADANI ENTERPRISES ₹253,405.0 Cr -2% -12.3% -8.1% Stock Analytics
REDINGTON ₹18,332.6 Cr 0.6% -12.8% -2.1% Stock Analytics
HONASA CONSUMER ₹8,754.1 Cr -6.3% -8% 26.1% Stock Analytics
MMTC ₹7,984.5 Cr -2.6% -19.6% 0.8% Stock Analytics
LLOYDS ENTERPRISES ₹7,272.5 Cr 1.3% -17.9% 20.9% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-0.2%

-15.4%

-71.8%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses